Healthcare

Google has announced a significant investment of €13 billion in Finland, marking its largest single investment in Europe, aimed at enhancing AI infrastructure. This package will include the construction of three new data centers and the expansion of an existing facility, in addition to a long-term agreement to purchase up to 50% of the electricity produced by the Loviisa nuclear power plant from Finnish utility Fortum. The initiative is expected to create over 37,000 construction jobs and contribute €3.6 billion annually to Finland's GDP. Finland's favorable conditions, such as its cool climate and low-carbon electricity supply, have made it an attractive locale for data center operations. This investment is part of a broader trend where technology companies are increasing their reliance on substantial power supplies to meet the growing demands of AI services. Along with Google, TikTok has also recently announced a $1 billion investment in Finland for a new data center, highlighting the country's strong digital infrastructure. Google’s commitment includes not only infrastructure development but also efforts to support local biodiversity and community initiatives, emphasizing a responsible approach to expansion. However, the environmental implications of such large-scale developments, particularly concerning energy consumption and resource allocation, raise concerns about the...

The article discusses two significant concerns regarding the deployment of AI technology and its implications. First, Reflect Orbital's plan to deploy space mirrors to beam sunlight to Earth could unintentionally disrupt the night sky and negatively impact wildlife, aviation, and astronomical observations due to the potential brightness of the beams. Studies suggest that these beams could shine as brightly as 10,000 full moons, raising valid safety and environmental concerns. On the second front, Insilico Medicine's recent experience in drug discovery highlights a critical issue in intellectual property law. While the company claimed that a promising drug for pulmonary fibrosis was 'discovered by' AI, it did not credit the AI in its patent application, naming only human inventors instead. This raises questions about the definition of inventorship in the context of AI contributions, complicating how intellectual property rights are assigned in future AI-driven discoveries. Both topics underline the complex ethical and regulatory challenges that arise from increasingly autonomous AI systems in society, emphasizing that AI is not neutral and that its deployment can have profound societal implications.

The article examines the intersection of artificial intelligence (AI) and intellectual property law, particularly in the context of drug discovery. It highlights the case of Insilico Medicine, a biotech company that utilized AI to develop a drug for pulmonary fibrosis but named only human inventors on the patent application. This discrepancy raises significant questions about the legal status of AI-generated inventions, as current laws only recognize humans as inventors. Legal expert Ryan Abbott's previous case involving an AI called DABUS serves as a reference point, illustrating the challenges in naming AI as an inventor due to existing statutes. The U.S. Patent and Trademark Office's inconsistent policies regarding AI inventor recognition contribute to a complex legal landscape that could hinder future innovation in drug development. The implications of this issue extend to broader discussions about how society defines invention and the role of AI in that process, as AI systems increasingly contribute to various creative fields. As the legal system grapples with these changes, the future of intellectual property rights and incentives for innovation in AI-driven sectors remains uncertain.

Discovered Materials is a startup focused on tackling overheating issues in data centers by leveraging artificial intelligence to discover new semiconductor materials. Founded by Advaith Sridhar and Akash Ramdas, the company uses AI agents to rapidly generate and test materials, greatly enhancing the speed of discovery compared to traditional methods. However, they face significant challenges in identifying materials that not only mitigate heat generation but are also viable for manufacturing. The potential for commoditization in material prediction poses concerns regarding the long-term sustainability of startups in this sector. While advancements in generative AI have been notable, with companies like Discovered Materials and others like MatNex and Citrine Informatics exploring innovative materials, the transition from discovery to real-world application remains slow. Experts point out that the primary bottleneck lies in filtering and synthesizing new candidates, emphasizing the necessity for practical lab work. This situation highlights the complexities in translating AI research into commercially viable products, prompting questions about the actual impact of AI on innovation in materials science and energy efficiency.

The Federal Trade Commission (FTC) has filed a lawsuit against Hims & Hers, a healthcare company that provides treatments for various conditions, including sexual wellness and mental health, for allegedly sharing sensitive customer health information with tech giants like Meta and Snap without user consent. The lawsuit claims that Hims & Hers utilized pixel tracking technology from these companies to capture and disclose users' health data, in violation of its own privacy policy. In addition to data sharing, the FTC has accused the company of misleading consumers about its privacy practices and using deceptive billing methods that made it difficult for customers to cancel services. The FTC's action is part of a broader crackdown on healthcare companies that mishandle patient data. Previous cases have involved other firms, including Cerebral and GoodRx, highlighting a growing concern over the privacy risks associated with the use of AI and digital tracking in healthcare. This situation underscores the potential risks of AI systems in handling sensitive data, raising questions about consumer trust and the ethical implications of data sharing practices in the healthcare sector.

Angelo Martino, a former ransomware negotiator in Florida, has been sentenced to over five years in prison for conspiring with hackers to deploy ransomware against U.S. companies. Alongside fellow cybersecurity professionals Kevin Martin and Ryan Goldberg, Martino was involved in orchestrating attacks using the BlackCat ransomware, extorting approximately $1.2 million from victims. The investigation revealed a disturbing trend of cybersecurity experts engaging in criminal activities while employed in protective roles, undermining public trust in the cybersecurity sector. Victims of these extortion attacks often face the dilemma of whether to pay ransoms to protect sensitive data, further complicating the issue. The rise of ransomware has also led to the establishment of a new insurance sector focused on handling such extortion cases, which raises questions about the effectiveness of these measures in deterring cybercrime. This incident highlights the potential for conflicts of interest within the cybersecurity industry and the broader implications for businesses and consumers alike as they navigate the increasingly hostile digital landscape.

The article reflects on Pope Leo XIV's encyclical, Magnifica Humanitas, which emphasizes the moral implications of artificial intelligence (AI) deployment in society. It highlights that AI is not neutral and is influenced by human choices, drawing a parallel with the biblical Tower of Babel, where the pursuit of unchecked growth led to chaos. The Pope advocates for a collective responsibility in shaping AI's future, urging stakeholders—from technologists to investors—to ensure that AI serves humanity and does not perpetuate harm, oppression, or environmental degradation. The encyclical calls for transparency, accountability, and ethical considerations in AI governance, noting the failure of existing regulatory frameworks to address these issues adequately. The piece underscores the necessity for investors and society to hold tech giants accountable for their AI practices, emphasizing that technology must align with human dignity and the common good.

As Americans increasingly seek health advice from AI, hospitals are developing branded chatbots to guide patients to their services, aiming to enhance convenience and provide safer alternatives to existing commercial options. However, experts raise concerns about the readiness and effectiveness of these chatbots in improving patient outcomes, as well as the potential risks associated with their use. While AI systems can offer quick responses and manage administrative tasks, they may lack the nuanced understanding necessary for diagnosing and treating complex health issues. Additionally, the deployment of chatbots could exacerbate existing inequalities in healthcare access, as not all patients possess equal digital literacy or access to technology. The push for AI solutions, driven by hospitals' desire to cut costs and improve efficiency, risks compromising the quality of patient care and leading to a depersonalized healthcare experience. As AI continues to integrate into healthcare, it is essential to critically assess its implications, ensuring that safety, transparency, and patient well-being remain priorities.

Hims & Hers, a telehealth company, has confirmed a data breach involving its third-party customer service platform, which occurred between February 4 and February 7. Hackers executed a social engineering attack, tricking employees into granting access to sensitive systems. The breach resulted in the theft of customer names, email addresses, and potentially other personal information, although the company asserts that medical records were not compromised. This incident highlights the increasing vulnerability of customer support systems to cyberattacks, particularly those motivated by financial gain. Such breaches can expose sensitive customer data, leading to privacy violations and potential identity theft. The full extent of the breach's impact remains unclear, as the company has not disclosed the number of affected individuals. This incident follows a trend where customer support databases have become lucrative targets for hackers, raising concerns about the security measures in place to protect sensitive information in telehealth and other sectors.

A significant data breach at Conduent, one of the largest government contractors in the U.S., has compromised the personal information of over 25 million individuals. The breach, attributed to a ransomware attack in January 2025, has raised serious concerns regarding the handling of sensitive data, as Conduent provides essential services for state government benefits and corporate unemployment operations. The stolen data includes names, Social Security numbers, health insurance information, and medical records. Despite the scale of the breach, Conduent has been criticized for its lack of transparency, providing minimal updates and making it difficult for affected individuals to access information about the incident. The breach is one of the largest recorded, trailing only behind a previous attack on Change Healthcare that affected over 190 million people. The incident highlights the vulnerabilities in cybersecurity practices, particularly in organizations handling vast amounts of personal data, and raises questions about accountability and the effectiveness of data protection measures in the face of increasing cyber threats.

A significant security vulnerability at DavaIndia Pharmacy, part of Zota Healthcare, exposed sensitive customer data and administrative controls to potential attackers. Security researcher Eaton Zveare identified the flaw, which stemmed from insecure 'super admin' application programming interfaces (APIs) that allowed unauthorized users to create high-privilege accounts. This breach compromised nearly 17,000 online orders and allowed unauthorized access to critical functions such as modifying product listings, pricing, and prescription requirements. The exposed data included personal information like names, phone numbers, and addresses, raising serious privacy and patient safety concerns. Although the vulnerability was reported to India's national cyber emergency response agency and was fixed shortly thereafter, the incident highlights the risks associated with inadequate cybersecurity measures in the rapidly expanding digital health sector. As DavaIndia continues to scale its operations, the implications of such vulnerabilities could have far-reaching effects on customer trust and safety in the healthcare industry.

The article highlights the efforts of biotech companies like Insilico Medicine and GenEditBio, which are leveraging artificial intelligence (AI) to address the labor shortages in drug discovery and gene editing for rare diseases. Insilico Medicine's president, Alex Aliper, emphasizes that AI can enhance the productivity of the pharmaceutical industry by automating processes that traditionally required large teams of scientists. Their platform can analyze vast amounts of biological, chemical, and clinical data to identify potential therapeutic candidates while reducing costs and development time. Similarly, GenEditBio is utilizing AI to refine gene delivery mechanisms, making it easier to edit genes directly within the body. By employing AI, these companies aim to tackle the challenges of curing thousands of neglected diseases. However, reliance on AI raises concerns about the implications of labor displacement and the potential risks associated with using AI in critical healthcare solutions. The article underscores the significance of AI's role in transforming healthcare, while also cautioning against the unintended consequences of such technological advancements.

French authorities have launched an investigation into X, the platform formerly known as Twitter, following accusations of data fraud and additional serious allegations, including complicity in the distribution of child sexual abuse material (CSAM) and privacy violations. The investigation, which began in 2025, has prompted a search of X's Paris office and the summoning of owner Elon Musk and former CEO Linda Yaccarino for questioning. The Cybercrime Unit of the Paris prosecutor's office is focusing on X's Grok AI, which has reportedly been used to generate nonconsensual imagery, raising concerns about the implications of AI systems in facilitating harmful behaviors. X has denied wrongdoing, stating that the allegations are baseless. The expanding scope of the investigation highlights the potential dangers of AI in enabling organized crime, privacy violations, and the spread of harmful content, thus affecting not only individuals who may be victimized by such content but also the broader community that relies on social platforms for safe interaction. This incident underscores the urgent need for regulatory frameworks that hold tech companies accountable for the misuse of their AI systems and protect users from exploitation and harm.